PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32866455-5	2020	Our results were conclusive and showed that both the racemic form, omeprazole and its pure S-enantiomer, esomeprazole, acted as potent mixed-competitive inhibitor of human ChAT with a global inhibition constant (Ki) of 88 nM (95%CI: 10-167nM) for esomeprazole and 178nM (95%CI: 140-230nM) for the racemic drug omeprazole.	Esomeprazole	105-117	choline O-acetyltransferase	Homo sapiens	172-176	
32866455-5	2020	Our results were conclusive and showed that both the racemic form, omeprazole and its pure S-enantiomer, esomeprazole, acted as potent mixed-competitive inhibitor of human ChAT with a global inhibition constant (Ki) of 88 nM (95%CI: 10-167nM) for esomeprazole and 178nM (95%CI: 140-230nM) for the racemic drug omeprazole.	Esomeprazole	247-259	choline O-acetyltransferase	Homo sapiens	172-176